Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

What is the Effectiveness and Safety of Mirtazapine Versus Escitalopram in Alleviating Cancer-associated Poly-symptomatology (MIR-P)? A Mixed-method Randomized Controlled Trial Protocol

NCT04763135 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT04763135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04763135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
What is the Effectiveness and Safety of Mirtazapine Versus Escitalopram in Alleviating Cancer-associated Poly-symptomatology (MIR-P)? A Mixed-method Randomized Controlled Trial Protocol
Lead sponsor
Hospices Civils de Lyon
Phase
Phase 3
Overall status
Terminated
Start date
December 15, 2021
Completion date
December 17, 2021
Enrollment
1 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, neoplasm metastasis, neoplasms